+1-855-874-6736 | CIG@trinseo.com
United States & Canada | Global Directory »

Editorial Information

Trinseo Targets Medical Sector with Biocompatible Glass-Filled Polycarbonate

CALIBRE™ 5000 Series supports growth in minimally-invasive surgeries and industry cost reduction

BERWYN, Pa. - Wednesday, October 31, 2018

Trinseo  (NYSE: TSE) a global materials solutions provider and manufacturer of plastics, latex binders and synthetic rubber, is targeting the medical devices market with its biocompatible glass-filled polycarbonate resins. Trinseo’s CALIBRE 5000 series is an ideal material for metal substitution not only because of its strength and stiffness, but its added advantages of aesthetics, ergonomic improvements, and potential cost savings.

“As minimally-invasive surgeries increase and cost pressures continue to mount, Trinseo’s glass-filled polycarbonate is ideal for a variety of surgical tools and surgery access instruments,” said Arthas Yang, global marketing manager in Trinseo’s Performance Plastics business. “The material can be incorporated into a variety of applications, according to design and regulatory requirements, and can help manufacturers with their goals of lowering cost and increasing speed-to-market.”

Glass-filled materials have been used in numerous application areas for years. What differentiates Trinseo’s CALIBRE™ 5000 series is the fact that it has undergone extensive biocompatibility testing according to ISO 10993 standards to provide medical device manufacturers with added assurance of compliancy and patient safety.  

The CALIBRE™ 5000 series offers the following:

  • Custom glass content of up to 30 percent
  • Full battery of ISO 10993 biocompatibility testing
  • UL flammability ratings
  • Sterilizable  by EtO, gamma, and e-beam radiation

From an aesthetic perspective the material can be colored for branding and parts-identification purposes. Due to its processability and the design flexibility it allows, parts can be consolidated for cost savings and simplified assembly, reducing the number of seams and crevasses where bacteria can grow.  

Trinseo has supported the medical devices market for three decades.  The company offers a variety of plastics under the brands CALIBRE™ and CALIBRE™ MEGARAD™ Polycarbonate Resins, EMERGE™ Advanced Resins, MAGNUM™ ABS  Resins, and STYRON™ Polystyrene Resins.  Thermoplastic elastomers offered by Trinseo for soft-touch medical applications are MEGOL™ MED TPS-SEBS Compounds and RAPLAN™ MED TPS-SBS Compounds.

About Trinseo

Trinseo (NYSE: TSE) is a global materials solutions provider and manufacturer of plastics, latex binders, and synthetic rubber. We are focused on delivering innovative and sustainable solutions to help our customers create products that touch lives every day — products that are intrinsic to how we live our lives — across a wide range of end-markets, including automotive, appliances, consumer electronics, medical devices, electrical, building and construction, textile, paper and board, footwear and tires. Trinseo had approximately $4.4 billion in net sales in 2017, with 16 manufacturing sites around the world, and approximately 2,200 employees. For more information visit www.trinseo.com

Note on Forward-Looking Statements

This press release may contain “forward-looking statements” within the meaning of the safe harbor provisions of the United States Private Securities Litigation Reform Act of 1995. Words such as “expect,” “estimate,” “project,” “budget,” “forecast,” “anticipate,” “intend,” “plan,” “may,” “will,” “could,” “should,” “believes,” “predicts,” “potential,” “continue,” and similar expressions are intended to identify such forward-looking statements. Forward-looking statements in this press release may include, without limitation, forecasts of growth, revenues, business activity, acquisitions, financings and other matters that involve known and unknown risks, uncertainties and other factors that may cause results, levels of activity, performance or achievements to differ materially from results expressed or implied by this press release. As a result of the foregoing considerations, you are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date of this press release. The Company undertakes no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events or otherwise.

Editorial Information